| 1 |
34125397 | Liposomal Form of L-Dopa and SH-Sy5y Cell-Derived Exosomes Modulate the Tyrosine Hydroxylase/Dopamine Receptor D2 Signaling Pathway in Parkinson's Rat Models. | 2021 Dec |
1 |
| 2 |
30353564 | The influence of SLC6A3 and DRD2 polymorphisms on levodopa-therapy in patients with sporadic Parkinson's disease. | 2019 Feb |
4 |
| 3 |
27779245 | Association between DRD2 and DRD3 gene polymorphisms and gastrointestinal symptoms induced by levodopa therapy in Parkinson's disease. | 2018 Jan |
3 |
| 4 |
28253352 | Dopamine D2 receptor and β-arrestin 2 mediate Amyloid-β elevation induced by anti-parkinson's disease drugs, levodopa and piribedil, in neuronal cells. | 2017 |
1 |
| 5 |
28687316 | Levodopa (L-DOPA) attenuates endoplasmic reticulum stress response and cell death signaling through DRD2 in SH-SY5Y neuronal cells under α-synuclein-induced toxicity. | 2017 Sep 1 |
3 |
| 6 |
28927418 | A systematic review and integrative approach to decode the common molecular link between levodopa response and Parkinson's disease. | 2017 Sep 19 |
1 |
| 7 |
25274160 | Central pharmacokinetics of levodopa: Lessons from imaging studies. | 2015 Jan |
1 |
| 8 |
25505120 | Dopamine regulates distinctively the activity patterns of striatal output neurons in advanced parkinsonian primates. | 2015 Mar 1 |
1 |
| 9 |
24705818 | Sustained increase of PKA activity in the postcommissural putamen of dyskinetic monkeys. | 2014 Dec |
2 |
| 10 |
23439215 | Task-dependent interactions between dopamine D2 receptor polymorphisms and L-DOPA in patients with Parkinson's disease. | 2013 May 15 |
5 |
| 11 |
23613810 | Genetic variation in the human brain dopamine system influences motor learning and its modulation by L-Dopa. | 2013 |
1 |
| 12 |
22751085 | Coadministration of domperidone increases plasma levodopa concentration in patients with Parkinson disease. | 2012 Jul-Aug |
1 |
| 13 |
23171335 | DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson's disease patients. | 2012 Nov |
2 |
| 14 |
23223310 | Rebalance of striatal NMDA/AMPA receptor ratio underlies the reduced emergence of dyskinesia during D2-like dopamine agonist treatment in experimental Parkinson's disease. | 2012 Dec 5 |
2 |
| 15 |
20026151 | Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys. | 2010 Apr 16 |
1 |
| 16 |
12796525 | L -dopa-induced adverse effects in PD and dopamine transporter gene polymorphism. | 2003 Jun 10 |
1 |
| 17 |
14683704 | Systemic sulpiride modulates striatal blood flow: relationships to spatial working memory and planning. | 2003 Dec |
1 |
| 18 |
11844900 | Downregulation of striatal dopamine D2 receptors in advanced Parkinson's disease contributes to the development of motor fluctuation. | 2002 |
2 |
| 19 |
11166288 | Effects of acute and repeated treatment with a novel dopamine D2 receptor ligand on L-DOPA-induced dyskinesias in MPTP monkeys. | 2001 Feb 2 |
1 |
| 20 |
10534246 | Dopamine D2 receptor gene polymorphism and the risk of levodopa-induced dyskinesias in PD. | 1999 Oct 22 |
2 |
| 21 |
9483165 | Pharmacodynamic and pharmacokinetic features of cabergoline. Rationale for use in Parkinson's disease. | 1998 |
1 |
| 22 |
8915594 | Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys. | 1996 Nov |
1 |
| 23 |
7884499 | Regional analysis of D2 dopamine receptors in Parkinson's disease using SPECT and iodine-123-iodobenzamide. | 1995 Mar |
1 |
| 24 |
7984527 | [Progressive supranuclear paralysis. Quantification of dopamine D2 receptors using radionuclide tomography]. | 1994 Sep 24 |
1 |
| 25 |
7901395 | Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- exposed monkeys. | 1993 Oct |
1 |
| 26 |
2950731 | Dopamine D2 receptor density in parkinsonian brain is constant for duration of disease, age, and duration of L-dopa therapy. | 1987 |
1 |